Dingwei Ye Selected Research

Drug Therapy (Chemotherapy)

1/2021	FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
1/2020	United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia.
1/2020	Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
9/2019	Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes.
1/2018	Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
10/2017	Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.
4/2017	A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia.
1/2017	Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
1/2016	Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study.
10/2015	Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dingwei Ye Research Topics

Disease

73	Neoplasms (Cancer) 01/2023 - 07/2009
65	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 11/2004
42	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 07/2009
22	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 07/2012
13	Neoplasm Metastasis (Metastasis) 05/2022 - 07/2009
8	Hypertension (High Blood Pressure) 05/2022 - 01/2014
7	Disease Progression 01/2020 - 07/2009
6	Carcinogenesis 11/2021 - 01/2015
5	Pain (Aches) 10/2021 - 01/2016
5	Penile Neoplasms (Penile Cancer) 01/2020 - 10/2015
4	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
4	Anemia 01/2021 - 01/2016
4	Obesity 04/2020 - 01/2016
4	Lymphatic Metastasis 05/2015 - 07/2009
2	Diarrhea 05/2022 - 03/2020
2	Proteinuria 05/2022 - 01/2015
2	Neutropenia 01/2022 - 01/2019
2	Fatigue 10/2021 - 11/2019
2	Leukopenia 01/2021 - 06/2019
2	Pneumonia (Pneumonitis) 01/2021 - 01/2019
2	Overweight 04/2020 - 01/2020
2	Thrombocytopenia (Thrombopenia) 03/2020 - 01/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 10/2017
2	Hand-Foot Syndrome 01/2019 - 02/2016
2	Hypokalemia 01/2017 - 01/2016
1	Tertiary Lymphoid Structures 08/2022
1	Drug-Related Side Effects and Adverse Reactions 05/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Circulating Neoplastic Cells 01/2022

Drug/Important Bio-Agent (IBA)

16	AndrogensIBA 01/2022 - 05/2013
14	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 08/2014
14	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2014
9	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2013
9	Messenger RNA (mRNA)IBA 12/2021 - 12/2010
6	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 01/2020
6	Docetaxel (Taxotere)FDA Link 01/2022 - 10/2015
6	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 08/2014
6	abirateroneIBA 01/2022 - 01/2016
6	Hormones (Hormone)IBA 01/2022 - 06/2019
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
5	Biological ProductsIBA 01/2022 - 09/2015
5	Sunitinib (Sutent)FDA Link 03/2020 - 05/2016
4	CytokinesIBA 01/2022 - 01/2014
4	AntigensIBA 01/2022 - 05/2018
4	Long Noncoding RNAIBA 11/2021 - 10/2016
4	apalutamideIBA 10/2021 - 01/2019
4	PlatinumIBA 01/2021 - 10/2017
4	enzalutamideIBA 10/2020 - 01/2020
4	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2016
4	Abiraterone AcetateIBA 01/2019 - 01/2016
4	Sorafenib (BAY 43-9006)FDA Link 08/2016 - 07/2009
3	NivolumabIBA 01/2023 - 08/2019
3	pazopanib FDA Link 05/2022 - 03/2020
3	LigandsIBA 01/2022 - 05/2018
3	Pharmaceutical PreparationsIBA 01/2020 - 02/2016
3	MicroRNAs (MicroRNA)IBA 01/2020 - 02/2013
3	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2015
3	AdiponectinIBA 01/2016 - 06/2015
2	EnzymesIBA 01/2023 - 07/2018
2	Everolimus FDA Link 01/2023 - 01/2018
2	Transaminases (Aminotransferases)IBA 05/2022 - 01/2021
2	Androgen Antagonists (Antiandrogens)IBA 01/2022 - 03/2020
2	TabletsIBA 01/2022 - 11/2019
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2019
2	ProteomeIBA 12/2021 - 10/2016
2	Immune Checkpoint ProteinsIBA 12/2021 - 01/2021
2	Peptides (Polypeptides)IBA 10/2021 - 09/2015
2	Small Interfering RNA (siRNA)IBA 01/2021 - 03/2019
2	tislelizumabIBA 01/2021 - 01/2020
2	InterferonsIBA 01/2021 - 01/2021
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020 - 07/2012
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2019
2	Circular RNAIBA 01/2020 - 03/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 01/2016
2	anlotinibIBA 01/2020 - 01/2019
2	Testosterone (Sustanon)FDA Link 06/2019 - 04/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 02/2016
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2016
2	Fluorine-18IBA 08/2012 - 07/2012
1	ChemokinesIBA 08/2022
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	DNA-Activated Protein KinaseIBA 01/2022
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2022
1	N(1)-methyl-2-pyridone-5-carboxylic acidIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Radioisotopes (Radionuclides)IBA 01/2022

Therapy/Procedure

40	Therapeutics 01/2023 - 01/2013
25	Castration 01/2022 - 10/2014
10	Drug Therapy (Chemotherapy) 01/2021 - 10/2015
10	Prostatectomy (Retropubic Prostatectomy) 04/2020 - 10/2011
5	Nephrectomy 01/2023 - 07/2009
5	Radiotherapy 01/2022 - 10/2017
5	Immunotherapy 12/2021 - 01/2021
5	Cystectomy 07/2020 - 01/2014
5	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 05/2015
3	Adjuvant Chemotherapy 05/2018 - 01/2017
2	Neoadjuvant Therapy 03/2017 - 01/2014
2	Transurethral Resection of Prostate (TURP) 01/2017 - 11/2004